Best Agrolife Limited — PPTs, 27-05-2025: Investor Presentation

**Financial Highlights:**

Best Agrolife reported a sharp turnaround with Q4 revenue rising 103% YoY to ₹274 Cr and EBITDA turning positive at ₹4 Cr from a ₹67 Cr loss a year ago. Q4 losses narrowed to ₹24 Cr from ₹92 Cr. Full-year revenue slightly dipped to ₹1,814 Cr from ₹1,873 Cr, while PAT loss improved to ₹22 Cr from ₹73 Cr. The balance sheet strengthened with a 25% cut in short-term borrowings to ₹453 Cr and inventory reduced by ₹185 Cr YoY, reflecting better working capital management.

**Strategic Initiatives & Growth Drivers:**

The company is investing ₹90 Cr (₹60 Cr funded) to expand Gajraula plant capacity, aiming to boost production. Efforts in geographic restructuring and team realignment are enhancing operational efficiency. Best Agrolife is prioritizing branded and patented agrochemicals, with specialty products and biopesticides targeted for FY26 to align with sustainable farming trends.

**Business Developments:**

Best Agrolife partnered strategically with Shanghai E-Tong Chemical for joint R&D and global market growth. It launched patented products including the herbicide Shot Down, addressing the ₹2,000 Cr soybean herbicide market. Upcoming launches include Bestman and Fetagen insecticides. Multiple patents on formulations and processes reinforce its innovation pipeline.

**Market Position & Competitive Advantage:**

Ranking as the 13th largest Indian agrochemical company, Best Agrolife’s portfolio features 66% branded-patented sales. Its edge comes from patented chemistries, a 10,900+ strong dealer network, and four manufacturing plants with 35,500 KL formulation capacity. Positive farmer feedback on Shot Down underscores its innovation leadership in Indian agro-science.

**Investor Implications:**

Margin improvement, loss reduction, strategic capex, and a robust branded pipeline signal promising growth potential. Execution of cost controls and product rollout will be critical. Investors should track plant expansion progress and commercialization of new products as drivers for sustained value creation.